Proliferative vitreoretinopathy (PVR) is a pathological process characterized by the formation of fibrotic membranes that contract and lead to recurrent retinal detachment. Pars plana vitrectomy (PPV) is the primary treatment, but recurrence rates remain high, as surgery does not address the underlying molecular mechanisms driving fibrosis. Despite several proposed pharmacological interventions, no approved therapies exist, partly due to challenges in conducting preclinical and in vivo studies for ethical and safety reasons. This review explores the potential of computational models and Digital Twins, which are increasingly gaining attention in medicine. These tools could enable the development of progressively complex PVR models, from basic simulations to patient-specific Digital Twins. Nintedanib, a tyrosine kinase inhibitor targeting PDGFR, VEGFR, and FGFR, is presented as a prototype for computational models to simulate its effects on fibrotic pathways in virtual patient cohorts. Although still in its early stages, the integration of computational models and Digital Twins offers promising avenues for improving PVR management through more personalized therapeutic strategies.
Proliferative vitreoretinopathy in retinal detachment: perspectives on building a digital twin model using Nintedanib / Visioli, Giacomo; Romaniello, Annalisa; Spinoglio, Leonardo; Albanese, GIUSEPPE MARIA; Iannetti, Ludovico; Gagliardi, OSCAR MATTEO; Lambiase, Alessandro; Gharbiya, Magda. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 25:20(2024), pp. 1-14. [10.3390/ijms252011074]
Proliferative vitreoretinopathy in retinal detachment: perspectives on building a digital twin model using Nintedanib
Visioli GiacomoPrimo
Writing – Review & Editing
;Romaniello AnnalisaSecondo
Writing – Original Draft Preparation
;Spinoglio LeonardoWriting – Review & Editing
;Albanese Giuseppe MariaWriting – Review & Editing
;Iannetti LudovicoValidation
;Gagliardi Oscar MatteoVisualization
;Lambiase AlessandroPenultimo
Supervision
;Gharbiya Magda
Ultimo
Conceptualization
2024
Abstract
Proliferative vitreoretinopathy (PVR) is a pathological process characterized by the formation of fibrotic membranes that contract and lead to recurrent retinal detachment. Pars plana vitrectomy (PPV) is the primary treatment, but recurrence rates remain high, as surgery does not address the underlying molecular mechanisms driving fibrosis. Despite several proposed pharmacological interventions, no approved therapies exist, partly due to challenges in conducting preclinical and in vivo studies for ethical and safety reasons. This review explores the potential of computational models and Digital Twins, which are increasingly gaining attention in medicine. These tools could enable the development of progressively complex PVR models, from basic simulations to patient-specific Digital Twins. Nintedanib, a tyrosine kinase inhibitor targeting PDGFR, VEGFR, and FGFR, is presented as a prototype for computational models to simulate its effects on fibrotic pathways in virtual patient cohorts. Although still in its early stages, the integration of computational models and Digital Twins offers promising avenues for improving PVR management through more personalized therapeutic strategies.File | Dimensione | Formato | |
---|---|---|---|
Visioli_Proliferative vitreoretinopathy_2024.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.96 MB
Formato
Adobe PDF
|
1.96 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.